CMLFU
Income statement / Annual
Last year (2024), CM Life Sciences, Inc.'s total revenue was $305.45 M,
and the percentage change from the previous year is not available.
In 2024, CM Life Sciences, Inc.'s net income was -$52.29 M.
See CM Life Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2020 |
| Operating Revenue |
$305.45 M |
$0.00 |
| Cost of Revenue |
$111.05 M
|
$0.00
|
| Gross Profit |
$194.40 M
|
$0.00
|
| Gross Profit Ratio |
0.64
|
0
|
| Research and Development Expenses |
$45.72 M
|
$0.00
|
| General & Administrative Expenses |
$101.11 M
|
$206.20 K
|
| Selling & Marketing Expenses |
$67.37 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$168.48 M
|
$206.20 K
|
| Other Expenses |
$0.00
|
$0.00
|
| Operating Expenses |
$214.20 M
|
$206.20 K
|
| Cost And Expenses |
$325.26 M
|
$206.20 K
|
| Interest Income |
$0.00
|
$0.00
|
| Interest Expense |
-$3.03 M
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$13.95 K
|
| EBITDA |
-$23.21 M |
-$192.00 K |
| EBITDA Ratio |
-0.08
|
0
|
| Operating Income Ratio |
-0.08
|
0
|
| Total Other Income/Expenses Net |
-$29.42 M
|
$13.95 K
|
| Income Before Tax |
-$52.63 M
|
-$192.00 K
|
| Income Before Tax Ratio |
-0.17
|
0
|
| Income Tax Expense |
-$343.00 K
|
$0.00
|
| Net Income |
-$52.29 M
|
-$192.00 K
|
| Net Income Ratio |
-0.17
|
0
|
| EPS |
-1.94 |
-0.0035 |
| EPS Diluted |
-1.94 |
-0.0035 |
| Weighted Average Shares Out |
$26.89 M
|
$55.34 M
|
| Weighted Average Shares Out Diluted |
$26.89 M
|
$55.34 M
|
| Link |
|
|
